Neogen Chemicals (NEOGEN)₹2,665+1.40%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Neogen Chemicals reported sales of ₹250 Cr, up 33.7% from Jun 2025, and net profit of ₹16.97 Cr, up 70.0% year on year. For the year to Mar 2026, sales were ₹863 Cr and net profit ₹28.92 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 162 | 164 | 200 | 180 | 193 | 201 | 203 | 187 | 209 | 220 | 247 | 250 |
| Expenses | 136 | 144 | 164 | 149 | 159 | 167 | 166 | 155 | 179 | 188 | 203 | 202 |
| Operating Profit | 25.95 | 19.97 | 35.97 | 30.97 | 34.94 | 34.98 | 35.96 | 31.96 | 29.95 | 31.96 | 43.95 | 47.96 |
| OPM % | 16.0% | 12.0% | 18.0% | 17.0% | 18.0% | 17.0% | 18.0% | 17.0% | 14.0% | 14.0% | 18.0% | 19.0% |
| Other Income | 1.99 | 1.99 | 1.99 | 1.99 | 0.99 | 0.99 | −12.94 | 0.99 | 1.99 | 1.99 | 0.99 | 3.98 |
| Interest | 10.99 | 10.99 | 9.99 | 9.99 | 12.99 | 12.99 | 11.99 | 12.99 | 18.98 | 21.99 | 20.99 | 20.98 |
| Depreciation | 6.02 | 6.03 | 6.02 | 7.02 | 7.02 | 7.03 | 7.03 | 6.03 | 7.02 | 7.02 | 8.04 | 8.03 |
| Profit before tax | 10.99 | 6.01 | 21.98 | 16.01 | 14.99 | 15.01 | 4.01 | 14.01 | 4.99 | 6.01 | 16.01 | 23.02 |
| Tax % | 27.9% | 81.0% | 24.9% | 26.9% | 29.0% | 34.0% | 34.9% | 27.9% | 35.0% | 35.9% | 28.0% | 25.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −7.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 7.99 | 0.99 | 16.97 | 10.98 | 10.97 | 9.98 | 1.99 | 9.98 | 2.99 | 3.99 | 10.97 | 16.97 |
| EPS (Rs) | 3.17 | 0.39 | 6.40 | 4.34 | 4.14 | 3.78 | 0.90 | 3.88 | 1.27 | 1.39 | 4.31 | 6.24 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 110 | 161 | 239 | 306 | 337 | 488 | 687 | 691 | 778 | 863 | 927 |
| Expenses | 85.94 | 90.02 | 132 | 196 | 248 | 272 | 401 | 574 | 580 | 641 | 725 | 772 |
| Operating Profit | 13.99 | 19.96 | 28.97 | 42.98 | 57.90 | 63.92 | 86.84 | 112 | 110 | 136 | 137 | 154 |
| OPM % | 14.0% | 18.0% | 18.0% | 18.0% | 19.0% | 19.0% | 18.0% | 16.0% | 16.0% | 18.0% | 16.0% | 16.6% |
| Other Income | 0.00 | 0.00 | 0.99 | 0.99 | 0.00 | 0.99 | 0.99 | 4.98 | 7.97 | −9.96 | 5.98 | 8.95 |
| Interest | 5.01 | 7.99 | 9.99 | 11.99 | 11.99 | 13.99 | 18.98 | 28.97 | 41.96 | 47.95 | 74.96 | 82.94 |
| Depreciation | 1.01 | 1.01 | 2.01 | 3.01 | 5.02 | 7.03 | 12.04 | 16.05 | 23.08 | 28.11 | 28.13 | 30.11 |
| Profit before tax | 8.01 | 12.01 | 17.01 | 29.02 | 41.01 | 44.03 | 56.98 | 71.01 | 52.96 | 50.01 | 41.03 | 50.03 |
| Tax % | 39.0% | 32.9% | 36.9% | 27.9% | 30.0% | 28.9% | 21.9% | 29.9% | 31.9% | 30.9% | 30.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −8.53 | 0.00 | 0.00 |
| Net Profit | 4.99 | 7.99 | 10.99 | 20.96 | 28.96 | 30.94 | 44.92 | 49.91 | 35.94 | 34.96 | 28.92 | 34.92 |
| EPS (Rs) | 2.58 | 3.83 | 5.48 | 10.40 | 12.26 | 13.40 | 17.88 | 20.00 | 13.47 | 13.17 | 10.88 | 13.21 |
| Dividend payout % | 17.1% | 0.0% | 18.0% | 14.1% | 16.1% | 17.0% | 15.1% | 15.0% | 15.1% | 8.1% | 18.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.99 | 20.02 | 19.95 | 19.96 | 19.96 | 22.94 | 22.95 | 24.95 | 24.92 | 25.93 | 25.96 | 25.92 |
| Reserves | 19.02 | 8.03 | 22.01 | 30.03 | 50.09 | 133 | 160 | 415 | 458 | 735 | 764 | 790 |
| Borrowings | 24.07 | 26.11 | 69.21 | 82.31 | 120 | 138 | 223 | 230 | 371 | 410 | 599 | 1,399 |
| Other Liabilities | 21.11 | 26.12 | 41.15 | 48.15 | 56.27 | 61.20 | 87.42 | 131 | 202 | 293 | 363 | 693 |
| Total Liabilities | 69.19 | 80.28 | 152 | 180 | 247 | 356 | 493 | 800 | 1,056 | 1,464 | 1,752 | 2,908 |
| Fixed Assets | 13.01 | 17.02 | 56.04 | 67.06 | 83.07 | 111 | 127 | 285 | 347 | 497 | 405 | 476 |
| CWIP | 0.00 | 1.01 | 1.01 | 1.01 | 0.00 | 3.01 | 115 | 11.01 | 36.03 | 109 | 156 | 858 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 81.71 | 76.66 | 0.00 | 0.00 | 0.00 |
| Other Assets | 55.18 | 62.25 | 94.27 | 112 | 164 | 242 | 251 | 423 | 596 | 859 | 1,192 | 1,575 |
| Inventories | 23.91 | 31.89 | 39.85 | 49.82 | 71.75 | 130 | 114 | 194 | 292 | 381 | 308 | 566 |
| Trade receivables | 17.97 | 15.96 | 31.93 | 40.91 | 60.87 | 74.81 | 78.89 | 110 | 177 | 282 | 200 | 379 |
| Cash & equivalents | 2.01 | 2.01 | 3.01 | 2.01 | 2.01 | 1.01 | 1.01 | 45.09 | 21.04 | 12.02 | 5.01 | 5.01 |
| Total Assets | 69.19 | 80.28 | 152 | 180 | 247 | 356 | 493 | 800 | 1,056 | 1,464 | 1,752 | 2,908 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 8.99 | 8.99 | 0.00 | 11.99 | −3.99 | −35.01 | 83.94 | 0.99 | −30.01 | −28.99 | 196 | −231 |
| Cash from investing activity | −2.01 | −4.01 | −33.01 | −13.02 | −20.01 | −29.02 | −135 | −146 | −94.01 | −216 | −317 | −411 |
| Cash from financing activity | −6.01 | −4.01 | 33.07 | 0.00 | 24.04 | 63.11 | 51.11 | 188 | 100 | 238 | 113 | 643 |
| Net cash flow | 1.01 | 0.00 | 1.01 | −1.01 | 0.00 | −1.01 | 0.00 | 44.12 | −25.07 | −8.02 | −8.02 | 0.00 |
| Capex | 1.99 | 3.99 | 31.96 | 13.99 | 17.95 | 26.96 | 22.94 | 170 | 104 | 302 | 317 | 555 |
| Free cash flow | 7.03 | 4.02 | −33.11 | −1.01 | −24.11 | −63.25 | −51.24 | −65.22 | −134 | −333 | −121 | −649 |
| CFO / OP % | 89.0% | 83.0% | 21.0% | 55.0% | 4.0% | −38.0% | 146.0% | 13.0% | −17.0% | −18.0% | 153.0% | −154.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 79 | 59 | 108 | 95 | 94 | 91 | 86 | 83 | 95 | 150 | 95 | 162 |
| Inventory days | 178 | 190 | 228 | 192 | 188 | 257 | 211 | 258 | 275 | 365 | 267 | 445 |
| Days payable | 120 | 130 | 177 | 141 | 111 | 71 | 122 | 131 | 147 | 138 | 227 | 346 |
| Cash conversion cycle | 137 | 118 | 159 | 146 | 170 | 277 | 175 | 210 | 224 | 377 | 135 | 261 |
| Working capital days | 141 | 127 | 175 | 49 | 64 | 96 | 67 | 112 | 80 | 130 | 124 | 86 |
| ROCE % | 27.0% | 26.0% | 23.0% | 23.0% | 26.0% | 22.1% | 17.0% | 14.0% | 13.0% | 9.1% | 9.0% | 6.0% |
For the Jun 2026 quarter, Neogen Chemicals reported sales of ₹250 Cr, up 33.7% year on year and net profit of ₹16.97 Cr, up 70.0% year on year. The operating margin was 19.0%.
Neogen Chemicals' sales for the year to Mar 2026 were ₹863 Cr; over the last twelve months they were ₹927 Cr.
Net profit for the year to Mar 2026 was ₹28.92 Cr, and ₹34.92 Cr over the last twelve months. Earnings per share over the same trailing period were ₹13.21.
Neogen Chemicals reported borrowings of ₹1,399 Cr at Mar 2026, against cash and equivalents of ₹5.01 Cr.
Cash from operations was −₹231 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹649 Cr.